Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report

por Centrone, Renato, Bellesso, Marcelo, Bonito, Debora, Dias, Daniela, Santucci, Rodrigo, Aranha, Milton, Alves, Adelson
Publicado 2020